First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 2.75 USD -2.14% Market Closed
Updated: Jun 10, 2024

Aquestive Therapeutics Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aquestive Therapeutics Inc
Total Current Assets Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Total Current Assets
$113.4m
CAGR 3-Years
37%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Current Assets
$57B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
0%
Bristol-Myers Squibb Co
NYSE:BMY
Total Current Assets
$28.7B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
7%
Pfizer Inc
NYSE:PFE
Total Current Assets
$42.4B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
-3%
Merck & Co Inc
NYSE:MRK
Total Current Assets
$31.4B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Eli Lilly and Co
NYSE:LLY
Total Current Assets
$25.2B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
7%

See Also

What is Aquestive Therapeutics Inc's Total Current Assets?
Total Current Assets
113.4m USD

Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Total Current Assets amounts to 113.4m USD.

What is Aquestive Therapeutics Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
15%

Over the last year, the Total Current Assets growth was 159%. The average annual Total Current Assets growth rates for Aquestive Therapeutics Inc have been 37% over the past three years , 15% over the past five years .